INS and type 2 diabetes mellitus: Maximizing estrogen signaling to β-cells via GLP-1 has been shown to reduce daily insulin needs by 60%, increase β-cell survival, and protect against cytokine-induced dysfunction in mouse models of T2D and in human micro-islets [358].